Abbott (ABT) Tops Q1 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Abbott Labs (ABT) PT Raised to $140 at Evercore ISI
April 16, 2025 11:38 AM EDTEvercore ISI analyst Vijay Kumar raised the price target on Abbott Labs (NYSE: ABT) to $140.00 (from $138.00) while maintaining a Outperform rating.
The analyst comments "Thesis Update: In an environment where uncertainty is the dominating theme, ability to protect bottom-line should be appreciated.... More
Stifel Reiterates Buy Rating on Abbott Labs (ABT)
April 16, 2025 8:47 AM EDTStifel analyst Rick Wise reiterated a Buy rating and $135.00 price target on Abbott Labs (NYSE: ABT).
The analyst comments "From our perspective, Abbott's first quarter report contained few surprises, both to the upside or the downside. First quarter 2025 numbers came in largely in-line with our own projections and Consensus estimates. Reported sales at $10.36B (+6.9% y/y) were in-line with our $10.35B... More
BTIG Reiterates Buy Rating on Abbott Labs (ABT)
April 16, 2025 8:46 AM EDTBTIG analyst Marie Thibault reiterated a Buy rating and $140.00 price target on Abbott Labs (NYSE: ABT).
The analyst comments "With adj. EPS two cents above expectations despite a minor sales miss, we think this was a solid quarter from Abbott. We breathe a sigh of relief to see ABT reaffirm its 2025 guide for sales, adj. operating margin, and adj. EPS. We think this matters most to investors. The company reported Q1 total revenue $10.358B (+6.9 y/y org. and +4.0% y/y rep.) that was ~$50M below consensus of $10.407B. Results were helped... More
